It was shown that BMP6 mRNA is expressed by both normal and malignant plasma cells, and that high levels of BMP6 in myeloma cells was associated with a favorable prognosis in multiple myeloma patients.27 This suggests that BMPs can have anti‐tumor effects in patients. Here, CLN5 is linked to plasma cell myeloma.